The androgen Inwniltlvlty syndrome iAIS) 1s a class~c e~aniple of a hormone resistance disorder. In the presence of a 46,XY Laryutype and normal or incrcased androgen levels, aifecled !nd~\,~duals have a female or ambiguous ektern~l genlt.il phenotype, result~ng from abnormal~t~es oi the inlraccllular androgrn receptor IARI, required lo mediate the actlon of androgens Usinc volvmerase cha~n re.,cuon. denaturinc cradlent eel electronhoresis and -. . To dcterni~ne \vhether a corrc>latlon exists between the specflic molecular defect and its cl~nfcal exDresslon. we li.ive an.ilvred tiww mutal>on~ dnd 70 renorted I)\, others \\,~th resocct to liw locallon, nature and funcifonal rllrcl5 a i thc AA rhdngc il>e rna)or$ty (89"A) 01 ~A'alleral~ons occurred In the steroid-btnd~ng domr~n ISBDI, 70% In the cenlral realon, encoded by exons E, F and C of the AR gene Mutations tn exons 0 2nd E predamlnant~y cause CAI5 ICAIS PAIS-4 4-11. In conlrdsl, mutattun, in exons F, C and H, encad~ngtlw C-tcrm~nal regLon of tl>e SBD, cause CAI5 or PAlS \i,ith farly equai Ilcqucncy 1CAIS.PAIS -1.2.1) Tlus suggests that the reglon rncoded by ?\on< D and E, plays a part~cularly cr~t~cdl role ~n AR function. Hlgl~l\, cli.lrged residues Arg ibai~c) an11 Asp lacldtc) are the most frequenlly .illrred 157% of CAIS, 44% of PAISI The phenotype r~5ulttng irom the AA (I~ange appears lo correlale ivlth the \ci9vr~ly of lhr <l~.,ng<. Lunvt,r.#nn ol Arg ti, .I ~ndrli,rlly d~licrenr AA, such ds Cy,, produces the CAI5 phc~iotypi*, ivhlle a con\rrvJti\e cl~.ingr, Arg lo 1115 Ialm a basic AA), is a,socldted iv~lli evgdence of dndrogen actton in vfvo and retentton of trdnsactlvatlon capacfty by the AR, when an~lyzrd in s8lro. A number of sites ~n thr i?K gene appear to br mutdlional "hot ipotr" lArg774, ArgB55, Va1866l although CAI5 or PAlS may occur with d~tlerent mutatlotis at the same site, no slngie mutation has yet been found that produces CAI5 In onc kfndred and PAIS ~n another. Analysis of recreated mutant receplors ~ndlcates that retention of androgendependent trdn,dcl,v.itlon acl8vlly 8 i i wli<i 'orrelalei In general \v~lh relrntlon of AR iunclion In vn,o These data may enable pied~ct~un of lhhely response to androgen In subjects with mutations cau,lng PAIS.
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GERhl CE1.L LOCALIZA'I'ION 01: TCSTICULAR GROWTII 110Rh10NE RELEASING HORhIONE tGlll<ll). P n r e w r , C Srivast:ivn, hl. Pcrcdo, I. Ilypothnl:t~iiic rcle:,\ing liormones h n \ e heen found outside o f the CNS, however, thcir extr.th! poili:,l:iniic functioii rcmains 1:trgely unlnown. We h:~ve identiried n te\t~cul:~r G l l R I l -l~L e peptidc and m R N A In human and r:~t testis I l u n~a~i leslis, Ithe liypotl~:il:ini~~s and p l :~~c n l a , contatns an :tbundant 750hp GIIRII niRNA. K:II te\tis h:ts been \Iiou,n to produce n I:lrger mRNA o f 1750bp. This arudy wits dcaigncd to loc:tlizc GIIRII productioli in testis Rat testes u.ere fr:tctionated followtiif coll.igen3se :tnd tqpsln d~gestion. Gem1 cells here funhcr sepnr:ited by sedt~neiit.itio~i. ultng 3 zi:iput device. Total RNA waa e\tractd from e:rh cell [)o[~t~l;~ttoti by ttie gi~:~tiidi~iiuiii I~I I O C~; I I~: I I~ nicthod. Nortlicm analysis, tlhlng : I 321'-1:tbelcd riOoliri,hc c<i:i~l~lcnient:try to : I G l l K l l cDNA (sift of R. Ev:~ns), reve:~lcd all :~b~li(l:tsit 17501111 tr:in\crijit in spcrni:ttocytes, round spcr~iint~il\ :itid. to ii Ie\ser ~h~e n t ,
iii Sertol~ cell\ NO tr.lnscr!pl U,:IS detected in RNA from e1011g:ttltig apr.r~~i:ttid\, Lcydig cells, o r cpidtdynits. Further loc:tliz:ttioii by i~i stir: lhybridtz:~tioli t~sttig tltis probe, reveliled proliillient lnb~lttig o f early aperiii:itogc~iic cell, Uec.tusc I111ni:tn germ cell cancer., are the result of dysregul:ited growth of utid~fiereiiti:ttr.<I speti~intoge~iic cells, u,e p~o b s d rlie 'Ter:~.
2 and NTIDI Ihttni:iii gcrrii cell c:tncer l i n o u,ttli (lie G l I R l l riboprobe. L~k e Iiypot11;tl;tniu~ ;ind 11uoi:in ii.iti\, ;I 750bp 1r:tnscrtpt w:ts clearly detecrablc in both cell li~iza T o detcrtnine I~G H R I I niight pl:ty :I role :is an nurocrtne ti~itogenic f:tctor 111 thcsc c:tncers, u e ev:llu.irsd tliymidi~ie ~ncorporntio~i into Ter:t-?. cells followi~ig tre:itiiicnt w l t l~ G l l R l l (100nhl) There w;is a 52% Increase in t l~y~i i~d t~i e incorpor:ttion buggcsting tIi:ir GIIRII can induce DNA s y n t l~e s~s In these cr.11,. Wc coiicludc tIi;t~ GIIKII 19 produced 111 nor~ii:tl i~n d cnncerous semi cell5 :111d ~~iccitI;tte t11;tt t t m:ry it~t~;t~ori :IS : I lcr:tl testicuI.tr g r o u t l~ fitctnr. 
a l g l a n d . A n e w b o r n f e m a l e , b o r n t o c o n s a n g u i n e o u s p a r e n t s , p r e s e n t e d w i t h s e v e r e s a l t -w a s t i n g . L a b o r a t o r y e v a l u a t i o n r e v e a l e d an i n c r e a s e d level of 1 8 -O H -C o r t i c u s t e r o n e c o n s i s t e n t w i t h t h e d i a g n o s i s of C M O I1 deficiency. S e g m e n t s o f t h e p a t i e n t ' s C Y P l l B 2 g e n e , as well a s t h a t o f h e r p a r e n t s a n d a n o r m a l control, w e r e a m p l i f i e d b y P C R u s i n g ;.j)c. .lie o l i g o n u c l e o t i d e p r i m e r s i n areas that d i f f e r e d f r o m t h e 93% homolugous CYPllBl g e n e . The PCR p r o d u c t s w e r e a n a l y z e d b y S o u t h e r n b l o t a n d r e v e a l e d a l a r g e m u t a t i o n o f t h e p a t i e n t ' s C Y P l l B 2 gene 5' o f e x o n 6. D o w n s t r e a m of e x o n 6, t h e r e a r e The p:ltienl ln Ihic stud) %.I\ Cushingo~d in appe3r:ince iilrli poor linc.ir gruniti hy 3 month\ of ngc. I:\.llu.~lion re\cJlcd clcvnicd icrum cui-lisol ilcspitc lo\r and h~gli dose dc\.rmeili.~sone siipprcl\io~i nnd u n d i , i c~l~b l c h.isclt~ic AC'III le\,els (<3 pg/mI). lie u n d c~x~c n l hll.1t~r.31 a d r e n :~I e~~o n~y \\,ill> S U~S U~U C~I I steroid r c~> I . l r e n~~n t . Adl-cn.11 hl,tolopy icvc.tlc.d bilaicr.11 :,dl-enororur.il dsrnl.tr~.$ s\llh lnodul~r elemcnu.
n o o t h e r g r o s s m u t a t i o n s . T h i s m u t a t i o n d i f f e r s f r o m t h o s e p r e v i o u s l y d e s c r i b e d i n t h e l i l e r a t u r e . F u r t h e r e v a l u a t i o n o f t h i s
. . Pediatric 3 e p a r t m e n t , I.11 : : u s s l a n ! i c s e a r c h C e n t r e f o r En- a n d a f t e r 6 n o n t h s o f p r e d n i s o l o n t r e a t m e n t . S a l i v a s a mp l e s w e r e t e k e n e v e r y 4 h o u r s o v e r 2 4 -h o u r p e r l o d . T h e n r e t r e a t r n e n t m e a s u r e m e n t r e v e a l e d a p r o n o u n c e d d i u r n a l r h y t h m o f s a l i v a 1 7 d -OJiP, w i t h t h e p e r s i s t e n t l y e l e v at e d l e v e l s t h r o u r r h o u t t h e d a y a n d n l c h t , r e a c h i n g a max l m m o f G 5 9 + 0 8 1 n y m l ~t 8.GO a n d -a n l m i m u m o f 1 , 3 1 + 0 , 5 3 n r / m l l a t -2 6 . 0 0 F p P , 0001 ). ~l l p a t i e n t s o n t h e r a p y s h o v i e d a n i a r k e d s u p r e s s l o l l o f 1 7 d -0iiP l e v e l s i n s a l i v a t h r o u g h o u t t h e a l l t l m e p o l n t s a n d t h e m a i n t e n a n c e o f t h e d i u r n a l r h y t h m o f t h e s t e r o l d w i t h t l i e n a x i m a l l e v e l s a t 8 . 0 0 ( 1 , 4 3 + 0 , 3 7 n d m l ) a n d m i n i m a l a t 2 0 -2 4 . 0 0 ( 0 , 4 3 + 0 , 1 7 n d m l , p < 0 , 0 0 1 ) . I n c o n c l u s i o n , t h e u s e of s a l i v a r y 1 7 6 -O M P a s s a y s , a n d e s p e c i a l l y it's c i r c a d i a n p e t t e r n s in n o n l t o r i n g o f t h e r a p y i n c h i l d r e n w i t h CAH i s v a l u -S24 a b l e a n d p e r s p e c t i v e .
